Rezultati pretrage - Nicholas Butowski

Detaljiziraj rezultate
  1. 1
    Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)

    Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis) od Eduardo Rodriguez Almaraz, Nicholas Butowski

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Recent Advances in Therapy for Glioblastoma

    Recent Advances in Therapy for Glioblastoma od Jennifer Clarke, Nicholas Butowski, Susan M. Chang

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    Treatment options for recurrent high-grade gliomas

    Treatment options for recurrent high-grade gliomas od Harjus Birk, Seunggu J. Han, Nicholas Butowski

    Izdano 2016
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

    A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM] od David R. Gibson, Anh Huan Vo, Hannah Lambing, Prithanjan Bhattacharya, Peggy Tahir, Farid Chehab, Nicholas Butowski

    Izdano 2024
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  5. 5
    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma

    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma od Mei‐Yin C. Polley, Kathleen R. Lamborn, Susan M. Chang, Nicholas Butowski, Jennifer Clarke, Michael D. Prados

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

    Mouse models of glioblastoma for the evaluation of novel therapeutic strategies od Alexander F. Haddad, Jacob S. Young, Dominic Amara, Mitchel S. Berger, David R. Raleigh, Manish K. Aghi, Nicholas Butowski

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  7. 7
    MRI Features and <i>IDH</i> Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis

    MRI Features and <i>IDH</i> Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis od Javier Villanueva-Meyer, Matthew D. Wood, Byung Se Choi, Marc C. Mabray, Nicholas Butowski, Tarık Tihan, Soonmee Cha

    Izdano 2017
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma

    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma od Seunggu J. Han, Caleb Rutledge, Annette M. Molinaro, Susan M. Chang, Jennifer Clarke, Michael D. Prados, Jennie Taylor, Mitchel S. Berger, Nicholas Butowski

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma

    Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma od Mario E. Lacouture, Mary E. Davis, Grace Elzinga, Nicholas Butowski, David Tran, John L. Villano, Lucianna DiMeglio, Angela M. Davies, Eric T. Wong

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma

    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma od Seunggu J. Han, John D. Rolston, Annette M. Molinaro, Jennifer Clarke, Michael D. Prados, Shannon Chang, Mitchel S. Berger, Annissa DeSilva, Nicholas Butowski

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma

    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma od Jennifer Clarke, Annette M. Molinaro, Joanna J. Phillips, Nicholas Butowski, Shannon Chang, Arie Perry, J Costello, Annissa DeSilva, Jane Rabbitt, Michael D. Prados

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma

    Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma od Edward Pan, Jeffrey G. Supko, Thomas Kaley, Nicholas Butowski, Timothy F. Cloughesy, Jinkyu Jung, Serena Desideri, Stuart A. Grossman, Xiaobu Ye, Deric M. Park

    Izdano 2016
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Quality of life in low-grade glioma patients receiving temozolomide

    Quality of life in low-grade glioma patients receiving temozolomide od Raymond Liu, Karla Solheim, Mei‐Yin C. Polley, Kathleen R. Lamborn, Margaretta Page, Anne Fedoroff, Jane Rabbitt, Nicholas Butowski, Michael D. Prados, Susan M. Chang

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

    Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143 od Antonio Omuro, David A. Reardon, John H. Sampson, Joachim M. Baehring, Solmaz Sahebjam, Timothy F. Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowski, Michael Lim

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)

    Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) od Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Yvonne Kew, Robert Cavaliere, John L. Villano, Daniela A. Bota, Jeremy Rudnick, Ashley Sumrall, Jay‐Jiguang Zhu, Nicholas Butowski

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)

    A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) od Nicholas Butowski, Susan M. Chang, Larry Junck, Lisa M. DeAngelis, Lauren E. Abrey, Karen Fink, Tim Cloughesy, Kathleen R. Lamborn, Andres Μ. Salazar, Michael D. Prados

    Izdano 2008
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma

    A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma od Kazim Narsinh, Karishma Kumar, Krystof Bankiewicz, Alastair J. Martin, Mitchel S. Berger, Jennifer Clarke, Jennie Taylor, Nancy Ann Oberheim Bush, Annette M. Molinaro, Manish K. Aghi, Nicholas Butowski

    Izdano 2025
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1

    Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1 od Michael D. Prados, Kathleen R. Lamborn, Susan M. Chang, Eric Burton, Nicholas Butowski, Mary Malec, A. Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley

    Izdano 2006
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma

    Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma od Susan M. Chang, Sarah J. Nelson, Scott R. VandenBerg, Soonmee Cha, Michael D. Prados, Nicholas Butowski, Michael McDermott, Andrew T. Parsa, Manish K. Aghi, Jennifer Clarke, Mitchel S. Berger

    Izdano 2009
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma

    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma od Jennie Taylor, Mili Parikh, Joanna J. Phillips, C. David James, Annette M. Molinaro, Nicholas Butowski, Jennifer Clarke, Nancy Ann Oberheim-Bush, Susan M. Chang, Mitchel S. Berger, Michael D. Prados

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: